Literature DB >> 25741453

The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.

Pengyuan Yang1, Geoffrey J Markowitz2, Xiao-Fan Wang2.   

Abstract

In contrast to a majority of cancer types, the initiation of hepatocellular carcinoma (HCC) is intimately associated with a chronically diseased liver tissue, with one of the most prevalent etiological factors being hepatitis B virus (HBV). Transformation of the liver in HBV-associated HCC often follows from or accompanies long-term symptoms of chronic hepatitis, inflammation and cirrhosis, and viral load is a strong predictor for both incidence and progression of HCC. Besides aiding in transformation, HBV plays a crucial role in modulating the accumulation and activation of both cellular components of the microenvironment, such as immune cells and fibroblasts, and non-cellular components of the microenvironment, such as cytokines and growth factors, markedly influencing disease progression and prognosis. This review will explore some of these components and mechanisms to demonstrate both underlying themes and the inherent complexity of these interacting systems in the initiation, progression, and metastasis of HBV-positive HCC.

Entities:  

Keywords:  cytokines; growth factors; hepatitis B; hepatocellular carcinoma; leukocytes; tumor microenvironment

Year:  2014        PMID: 25741453      PMCID: PMC4346158          DOI: 10.1093/nsr/nwu038

Source DB:  PubMed          Journal:  Natl Sci Rev        ISSN: 2053-714X            Impact factor:   17.275


  175 in total

1.  Hepatitis B virus X protein stimulates the Hedgehog-Gli activation through protein stabilization and nuclear localization of Gli1 in liver cancer cells.

Authors:  Hye Young Kim; Hyun Kook Cho; Sung Pyo Hong; Jaehun Cheong
Journal:  Cancer Lett       Date:  2011-06-24       Impact factor: 8.679

2.  Coronary sinus pressure and arterial venting do not affect retrograde cardioplegia distribution.

Authors:  A H Huang; I O Sofola; B L Bufkin; R J Mellitt; R A Guyton
Journal:  Ann Thorac Surg       Date:  1994-11       Impact factor: 4.330

3.  The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma.

Authors:  Jian Sun; Hong-Mei Xu; Hai-Jun Zhou; Qiong-Zhu Dong; Yue Zhao; Li-Yun Fu; Zhen-Yu Hei; Qing-Hai Ye; Ning Ren; Hu-Liang Jia; Lun-Xiu Qin
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

Review 4.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

Review 5.  MicroRNAs in the tumour microenvironment: big role for small players.

Authors:  Patsy Soon; Hippokratis Kiaris
Journal:  Endocr Relat Cancer       Date:  2013-08-23       Impact factor: 5.678

Review 6.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells.

Authors:  Lian Qiu Wu; Wen Jian Zhang; Ji Xiao Niu; Li Ya Ye; Zhi Hua Yang; Georges E Grau; Jin Ning Lou
Journal:  J Vasc Res       Date:  2007-09-27       Impact factor: 1.934

8.  Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes.

Authors:  Peter Vanlandschoot; Annelies Roobrouck; Freya Van Houtte; Geert Leroux-Roels
Journal:  Biochem Biophys Res Commun       Date:  2002-09-27       Impact factor: 3.575

9.  Nivolumab plus ipilimumab in advanced melanoma.

Authors:  Jedd D Wolchok; Harriet Kluger; Margaret K Callahan; Michael A Postow; Naiyer A Rizvi; Alexander M Lesokhin; Neil H Segal; Charlotte E Ariyan; Ruth-Ann Gordon; Kathleen Reed; Matthew M Burke; Anne Caldwell; Stephanie A Kronenberg; Blessing U Agunwamba; Xiaoling Zhang; Israel Lowy; Hector David Inzunza; William Feely; Christine E Horak; Quan Hong; Alan J Korman; Jon M Wigginton; Ashok Gupta; Mario Sznol
Journal:  N Engl J Med       Date:  2013-06-02       Impact factor: 91.245

10.  Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients.

Authors:  Ahmed A Al-Qahtani; Mashael R Al-Anazi; Ayman A Abdo; Faisal M Sanai; Waleed Al-Hamoudi; Khalid A Alswat; Hamad I Al-Ashgar; Nisreen Z Khalaf; Abdelmoneim M Eldali; Nisha A Viswan; Mohammed N Al-Ahdal
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more
  28 in total

Review 1.  Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Chiao-Fang Teng; Han-Chieh Wu; Woei-Cherng Shyu; Long-Bin Jeng; Ih-Jen Su
Journal:  Cell Transplant       Date:  2017-02-14       Impact factor: 4.064

2.  CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.

Authors:  Yunching Chen; Rakesh R Ramjiawan; Thomas Reiberger; Mei R Ng; Tai Hato; Yuhui Huang; Hiroki Ochiai; Shuji Kitahara; Elizabeth C Unan; Tejaswini P Reddy; Christopher Fan; Peigen Huang; Nabeel Bardeesy; Andrew X Zhu; Rakesh K Jain; Dan G Duda
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

3.  Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes.

Authors:  Geoffrey J Markowitz; Pengyuan Yang; Jing Fu; Gregory A Michelotti; Rui Chen; Jianhua Sui; Bin Yang; Wen-Hao Qin; Zheng Zhang; Fu-Sheng Wang; Anna Mae Diehl; Qi-Jing Li; Hongyang Wang; Xiao-Fan Wang
Journal:  Cancer Res       Date:  2016-02-18       Impact factor: 12.701

4.  Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma.

Authors:  Geoffrey J Markowitz; Gregory A Michelotti; Anna Mae Diehl; Xiao-Fan Wang
Journal:  Sci Bull (Beijing)       Date:  2015-04-01       Impact factor: 11.780

5.  Management of hepatocellular carcinoma rupture in the caudate lobe.

Authors:  De-Fei Hong; Ying-Bin Liu; Shu-You Peng; Jin-Zhong Pang; Zhi-Fei Wang; Jian Cheng; Guo-Liang Shen; Yuan-Biao Zhang
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 6.  Zebrafish as a disease model for studying human hepatocellular carcinoma.

Authors:  Jeng-Wei Lu; Yi-Jung Ho; Yi-Ju Yang; Heng-An Liao; Shih-Ci Ciou; Liang-In Lin; Da-Liang Ou
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 7.  Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma.

Authors:  Yinli Yang; Bingqing Zheng; Qiuju Han; Cai Zhang; Zhigang Tian; Jian Zhang
Journal:  Cancer Biol Ther       Date:  2016-04-02       Impact factor: 4.742

8.  Studied microRNA gene expression in human hepatocellular carcinoma by microRNA microarray techniques.

Authors:  Jian-Xiang Niu; Xing-Kai Meng; Jian-Jun Ren
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

9.  Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines.

Authors:  Zhikui Cheng; Ge Sun; Wei Guo; Yayun Huang; Weihua Sun; Fei Zhao; Kanghong Hu
Journal:  Virol Sin       Date:  2015-08-08       Impact factor: 4.327

10.  Somatic mutation profiling of liver and biliary cancer by targeted next generation sequencing.

Authors:  Bo-Lun Zhang; Xu Ji; Ling-Xiang Yu; Yuan Gao; Chao-Hui Xiao; Jia Liu; De-Xi Zhao; Yi Le; Guang-Hao Diao; Jia-Yi Sun; Gao-Hua Li; Guang-Lin Lei; Peng Yu; Rui-Lan Wang; Jian-Zhong Wu; Peng-Hui Yang; Jin Yan; Jing-Yu Li; Jia-Jia Xu; Shao-Geng Zhang; Hu Tian
Journal:  Oncol Lett       Date:  2018-08-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.